http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Avantor® Expands Centralized Service Center Model with Opening of Boston-Area Facility
-
Marks & Spencer Launches Re:Spark to Ignite Renewable Electricity Adoption Across Its Supply Chain
-
XiFin, Inc. Achieves Seventh Consecutive #1 Client Experience Rating in Laboratory and Ancillary Revenue Cycle Services, Black Book 2025 Survey
-
Metrospaces Inc. Announces Launch of "MSPC Coin," a Community-Driven Digital Token Powered by the OTCM Protocol
-
Soligenix hits enrollment target for HyBryte lymphoma trial interim analysis
-
Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
-
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
-
Lightbridge begins reactor testing of nuclear fuel samples at Idaho lab
-
Rekor Systems patents privacy framework for license plate recognition
-
Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials
-
Lightbridge Announces Start of Irradiation Testing of its Enriched Uranium-Zirconium Alloy Samples in Advanced Test Reactor at Idaho National Laboratory
-
Rekor Systems Offers Policymakers a Privacy-Protected and Responsible Path Forward for the Use of Automated License Plate Recognition
-
Echo Emerges as the Signal in the Noise: The First Operating System for Living Science
-
Merck HIV drug combo meets phase 3 trial goals for treatment-naive patients
-
Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Na
-
European Commission approves subcutaneous KEYTRUDA for all adult indications
-
European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union
-
Office of His Highness Sheikh Hamdan Bin Ahmed Al Maktoum Holdings Announces the Official Launch of the GTBS Digital Ecosystem on December 25
-
ESET Research: Chinese PlushDaemon group compromises network devices for adversary-in-the-middle attacks
-
New Project to Make AI in Broadband a Reality
-
KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer at MEDICA 2025
-
Pacsun Successfully Implements Manhattan Active® Point of Sale, Unifying Commerce and Cutting Checkout Times
-
Schneider Electric Transforms U.S. Asset Performance Management Services to Deliver Integrated, Proactive Experience to Simplify Critical Infrastructure Management
-
Fobi AI Announces Appointment of New Auditor
-
Schneider Electric, AVEVA and ETAP Join Alliance for OpenUSD to Advance Digital Twins and 3D Modeling for Industries
-
Introducing the All-new, All-electric 2026 Jeep® Recon: Trail Rated Capability, Electrified
-
Schneider Electric Becomes First Company to Earn UL ECOLOGO® Certification for Energy and Industrial Automation Equipment
-
Greenberg Traurig Advises European Dental Group on Acquisition of Majority Stake in Fresh Tandartsen
-
Resverlogix Appoints Bradley Glass to Board of Directors
-
Union Pacific Corporation Declares Fourth Quarter 2025 Dividend
-
Eledon reports early diabetes trial results for tegoprubart drug
-
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at U
-
IMAX to Host Investor Day on December 4, 2025
-
Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference
-
Prime Healthcare Named One of the Nation’s Top 10 Health Systems for Patient Safety
-
Check Point partners with Microsoft for AI security in Copilot Studio
-
Check Point Software Collaborates with Microsoft to Deliver Enterprise-Grade AI Security for Microsoft Copilot Studio
-
Rubrik integrates Agent Cloud with Microsoft Copilot Studio
-
Rubrik launches business recovery tools for Microsoft 365 and DevOps platforms
-
Rubrik Agent Cloud Accelerates Trusted Agentic AI Deployments for Microsoft Copilot Studio
-
Cribl Expands Collaboration with Microsoft, Simplifies Real-Time Insights with Dedicated Microsoft Fabric Real-Time Intelligence Integration
-
Rubrik Introduces Intelligent Business Recovery for Microsoft 365 and DevOps Protection for Microsoft Environments
-
Arctic Wolf Launches New Integration with Abnormal AI to Enhance Email Threat Detection and Response
-
1-800TRUCKWRECK AND NEW BIRTH MISSIONARY BAPTIST CHURCH TO FEED 4,000 FAMILIES IN ONE OF METRO ATLANTA’S LARGEST THANKSGIVING GIVEAWAYS
-
Canadian Securities Exchange Reports October 2025 Performance Figures
-
Detroit Free Press Recognizes Aledade with 2025 Michigan Top Workplace Award
-
Greenberg Traurig's Lynelle K. Bosworth and Elizabeth Colombo Garvey Recognized on City & State's 2025 'Women Power 100' List
-
Schneider Electric's EcoStruxure™ Foresight Operation Ushers in a New Era for the Built Environment
-
AbbVie receives FDA approval for EPKINLY combination therapy for lymphoma
-
AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma
